B-cell Lymphoma
Showing NaN - NaN of 10
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CD19/CD22-bispecific CAR-T cells
-
Beijing, Beijing, ChinaLiang Wang
Oct 7, 2023
B-cell Lymphoma Trial in Beijing (Relmacabtagene Autoleucel, Fludarabine, Cyclophosphamide)
Not yet recruiting
- B-cell Lymphoma
- Relmacabtagene Autoleucel
- +2 more
-
Beijing, Beijing, China
- +1 more
Oct 19, 2022
r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase
Not yet recruiting
- B-cell Lymphoma
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Aug 9, 2022
B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)
Recruiting
- B-cell Lymphoma
- LP-168 tablet
-
Beijing, Beijing, China
- +2 more
Feb 24, 2022
B-Cell Lymphoma Trial in Beijing (GB241, Rituximab)
Completed
- B-Cell Lymphoma
- GB241
- Rituximab
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 19, 2021
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in Beijing (PZ01 CAR-T cells)
Unknown status
- B-cell Acute Lymphoblastic Leukemia
- B-cell Lymphoma
- PZ01 CAR-T cells
-
Beijing, Beijing, ChinaDepartment of Hematology, Navy General Hospital of PLA
Sep 14, 2017